These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 25133063)

  • 1. Mixed Specifier for Bipolar Mania and Depression: Highlights of DSM-5 Changes and Implications for Diagnosis and Treatment in Primary Care.
    Hu J; Mansur R; McIntyre RS
    Prim Care Companion CNS Disord; 2014; 16(2):. PubMed ID: 25133063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
    Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bipolar II disorder : epidemiology, diagnosis and management.
    Benazzi F
    CNS Drugs; 2007; 21(9):727-40. PubMed ID: 17696573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Should major depressive disorder with mixed features be classified as a bipolar disorder?
    Liu X; Jiang K
    Shanghai Arch Psychiatry; 2014 Oct; 26(5):294-6. PubMed ID: 25477723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Undiagnosed Bipolar Disorders in Patients with Major Depressive Episode: Iran's part of a Multicenter Cross-Sectional Study.
    Abhari SA; Sadeghi M; Ardestani SM; Semnani Y; Mirsepassi G; Sadr SS; Kamaloo A; Ahadi M; Pourmirza B; Mir E
    Iran J Psychiatry; 2013 Mar; 8(1):1-6. PubMed ID: 23682245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and characteristics of undiagnosed bipolar disorders in patients with a major depressive episode: the BRIDGE study.
    Angst J; Azorin JM; Bowden CL; Perugi G; Vieta E; Gamma A; Young AH;
    Arch Gen Psychiatry; 2011 Aug; 68(8):791-8. PubMed ID: 21810644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treating mixed mania/hypomania: a review and synthesis of the evidence.
    Takeshima M
    CNS Spectr; 2017 Apr; 22(2):177-185. PubMed ID: 28004626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mixed depression and DSM-5: A critical review].
    Weibel S; Bertschy G
    Encephale; 2016 Feb; 42(1):90-8. PubMed ID: 26471516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pilot study differentiating recurrent major depression from bipolar disorder cycling on the depressive pole.
    Hinz M; Stein A; Uncini T
    Neuropsychiatr Dis Treat; 2010 Nov; 6():741-7. PubMed ID: 21173882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guidelines for the recognition and management of mixed depression.
    Stahl SM; Morrissette DA; Faedda G; Fava M; Goldberg JF; Keck PE; Lee Y; Malhi G; Marangoni C; McElroy SL; Ostacher M; Rosenblat JD; Solé E; Suppes T; Takeshima M; Thase ME; Vieta E; Young A; Zimmerman M; McIntyre RS
    CNS Spectr; 2017 Apr; 22(2):203-219. PubMed ID: 28421980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ECNP consensus meeting. Bipolar depression. Nice, March 2007.
    Goodwin GM; Anderson I; Arango C; Bowden CL; Henry C; Mitchell PB; Nolen WA; Vieta E; Wittchen HU
    Eur Neuropsychopharmacol; 2008 Jul; 18(7):535-49. PubMed ID: 18501566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Making sense of DSM-5 mania with depressive features.
    Reinares M; Bonnín Cdel M; Hidalgo-Mazzei D; Undurraga J; Mur M; Nieto E; Sáez C; Vieta E
    Aust N Z J Psychiatry; 2015 Jun; 49(6):540-9. PubMed ID: 25943979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis.
    Benazzi F; Berk M; Frye MA; Wang W; Barraco A; Tohen M
    J Clin Psychiatry; 2009 Oct; 70(10):1424-31. PubMed ID: 19906346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenomenology of manic episodes according to the presence or absence of depressive features as defined in DSM-5: Results from the IMPACT self-reported online survey.
    Vieta E; Grunze H; Azorin JM; Fagiolini A
    J Affect Disord; 2014 Mar; 156():206-13. PubMed ID: 24439831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measures of the DSM-5 mixed-features specifier of major depressive disorder.
    Zimmerman M
    CNS Spectr; 2017 Apr; 22(2):196-202. PubMed ID: 28077190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and clinical significance of subsyndromal manic symptoms, including irritability and psychomotor agitation, during bipolar major depressive episodes.
    Judd LL; Schettler PJ; Akiskal H; Coryell W; Fawcett J; Fiedorowicz JG; Solomon DA; Keller MB
    J Affect Disord; 2012 May; 138(3):440-8. PubMed ID: 22314261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cariprazine efficacy in bipolar I depression with and without concurrent manic symptoms: post hoc analysis of 3 randomized, placebo-controlled studies.
    McIntyre RS; Suppes T; Earley W; Patel M; Stahl SM
    CNS Spectr; 2020 Aug; 25(4):502-510. PubMed ID: 31576791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical characterization of depressive mixed state in bipolar-I patients: Pisa-San Diego collaboration.
    Perugi G; Akiskal HS; Micheli C; Toni C; Madaro D
    J Affect Disord; 2001 Dec; 67(1-3):105-14. PubMed ID: 11869757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A clinically useful self-report measure of the DSM-5 mixed features specifier of major depressive disorder.
    Zimmerman M; Chelminski I; Young D; Dalrymple K; Martinez JH
    J Affect Disord; 2014 Oct; 168():357-62. PubMed ID: 25103631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology, diagnosis and management of mixed mania.
    González-Pinto A; Aldama A; Mosquera F; González Gómez C
    CNS Drugs; 2007; 21(8):611-26. PubMed ID: 17630815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.